- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Big Green Snowflakes
Swiss Pharmaceuticals & Biotech Big Green Snowflakes
Results
23
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
23 companies
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 62.80
7D
-4.7%
1Y
-16.4%
Novartis
Market Cap: CHF 190.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 98.40
7D
0.1%
1Y
1.3%
Newron Pharmaceuticals
Market Cap: CHF 209.2m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 10.48
7D
0.8%
1Y
37.9%
Roche Holding
Market Cap: CHF 217.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 253.50
7D
-6.5%
1Y
-6.3%
Tecan Group
Market Cap: CHF 1.8b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 145.60
7D
-8.0%
1Y
-47.7%
Bachem Holding
Market Cap: CHF 4.3b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 57.70
7D
-11.2%
1Y
-19.0%
Siegfried Holding
Market Cap: CHF 3.4b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 78.20
7D
-6.5%
1Y
-31.3%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 53.80
7D
-5.6%
1Y
-32.5%
Lonza Group
Market Cap: CHF 36.7b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 522.20
7D
-3.4%
1Y
-2.3%
Basilea Pharmaceutica
Market Cap: CHF 555.4m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 45.20
7D
-3.7%
1Y
-2.5%
Molecular Partners
Market Cap: CHF 104.5m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 2.80
7D
-0.9%
1Y
-36.0%
Kuros Biosciences
Market Cap: CHF 877.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.72
7D
-1.0%
1Y
24.0%
PolyPeptide Group
Market Cap: CHF 781.9m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 23.70
7D
-7.4%
1Y
-22.3%
Galderma Group
Market Cap: CHF 32.1b
Operates as a dermatology company worldwide.
GALD
CHF 135.40
7D
-4.4%
1Y
72.3%
BioVersys
Market Cap: CHF 166.6m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 28.50
7D
-9.5%
1Y
n/a
Dottikon ES Holding
Market Cap: CHF 4.1b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.
DESN
CHF 293.50
7D
0.2%
1Y
13.3%
Xlife Sciences
Market Cap: CHF 115.4m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 20.00
7D
0.5%
1Y
-35.1%
Sandoz Group
Market Cap: CHF 20.1b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 46.74
7D
-2.9%
1Y
32.5%
Addex Therapeutics
Market Cap: CHF 6.4m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.065
7D
-0.3%
1Y
-3.8%
Relief Therapeutics Holding
Market Cap: CHF 40.0m
A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.
RLF
CHF 3.18
7D
6.7%
1Y
25.7%
Idorsia
Market Cap: CHF 763.0m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.65
7D
-6.4%
1Y
144.3%
Santhera Pharmaceuticals Holding
Market Cap: CHF 140.8m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 10.86
7D
-21.6%
1Y
22.7%
Curatis Holding
Market Cap: CHF 72.4m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 14.50
7D
3.6%
1Y
65.5%